Abstract Body

Background: Elite suppressors (ES) are HIV-1 infected patients who maintain undetectable viral loads without antiretroviral therapy. The control has previously been associated with a qualitatively superior CD8+ T cell response to infected CD4+ T cells. However, very few studies have examined the effector T cell response to HIV-1 infected macrophages. In the macaque ES model, both CD4+ and CD8+ T cell clones are capable of suppressing infection in macrophages, but in an ex vivo study, SIV-specific primary CD8+ T cells were far less effective at inhibiting viral replication in macrophages than in CD4+ T cells. In this study, we examined the CD4+ and CD8+ effector T cell responses to HIV-1 infected monocyte-derived macrophages (MDM). Methodology: Monocytes were isolated from 10 uninfected healthy donors (HD) and 7 ES and cultured in macrophage differentiation media (RPMI, 20% human AB serum, 1% HEPES, 50 ng hrM-CSF/mL) for 7 days before infection. On the day of infection, the MDMs were infected with the laboratory isolate Ba-L by spinoculation. Unstimulated primary CD4+ and CD8+ cells isolated from a second blood draw were added to the MDMs at various effector to target ratios immediately after infection. Normalized percent inhibition of viral replication was calculated by comparing culture supernatant p24 levels in the presence and absence of effector CD8+ or CD4+ T cells, and unpaired, two-way Student’s T-tests were used to determine statistical significance. Results: There was no difference in the rate of viral replication in MDMs isolated from ES and HD (p > .7). ES effector T cells were capable of suppressing viral production in MDMs. By day 7, CD4+ effector T cells inhibited viral production in MDMs by 56.8 } 11.2% (mean } SE; range: 23.0-92.7%), and CD8+ effector T cells inhibited virus production in MDMs by 84.4 } 9.2% (range: 36.0-99.3%), with the CD8+ effect tending to be stronger (p < .1). Conversely, inhibition in HD was significantly lower with an average inhibition of 17.1 } 8.2% and 12.4 } 7.7%, respectively (CD4s: p < .02, CD8s: p < 10-4). These differences were apparent as early as the third day post infection (p < .05). Interestingly, separation of effector cells from target cells with transwells resulted in complete abrogation of the inhibitory response by CD8+ T cells and partial abrogation of the CD4+ T cell response. Conclusions: Primary unstimulated effector CD4+ and CD8+ T cells from ES are capable of effectively inhibiting viral replication in MDMs in vitro in a cellcell contact mediated manner. The degree of CD8+ T cell mediated inhibition of viral replication in MDMs was comparable to that seen in target CD4+ T cells. These observations imply that the response of effector cells to macrophages should be considered in rational vaccine design and the continuing goal of eradication.